Use of an electronic nose to distinguish cerebrospinal fluid from serum

被引:18
|
作者
Thaler, ER
Bruney, FC
Kennedy, DW
Hanson, CW
机构
[1] Univ Penn, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA
关键词
D O I
10.1001/archotol.126.1.71
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Efforts to mimic the biologic olfactory system have resulted in the development of an electronic nose, whereby volatile gases may be identified by means of organic semiconductors. Such devices have been used in the food and beverage industry for quality-control purposes, but to date have not been used in the field of medicine. Objective: To present the application of an electronic nose for clinical decision making by assessing the ability of an electronic nose to distinguish cerebrospinal fluid (CSF)from serum. Design: Randomized, prospective, masked study. Subjects: Nineteen matched sets of CSF and serum from inpatients at a university hospital. Results: The electronic nose was able to distinguish CSF from serum in 18 of 19 patients. The data points for 18 of 19 CSF and 18 of 19 serum samples were within statistically :distinct cluster groups, suggesting that the device is able to identify an unknown sample as CSF or serum. Conclusions: This new technology is able to distinguish CSF from serum with a high degree of accuracy and speed; and with small sample quantity, potentially allowing the physician to identify reliably CSF otorrhea or rhinorrhea. This revolutionary diagnostic approach may have further, widespread application in the field of otorhinolaryngology and in medicine as a whole.
引用
收藏
页码:71 / 74
页数:4
相关论文
共 50 条
  • [31] Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study
    Matsumoto, Kazumasa
    Murakami, Yasukiyo
    Shimizu, Yuriko
    Hirayama, Takahiro
    Ishikawa, Wataru
    Iwamura, Masatsugu
    CANCER BIOMARKERS, 2020, 28 (01) : 33 - 39
  • [32] Inorganic constituents of cerebrospinal fluid. IV. The potassium in serum, serum-ultrafiltrate and cerebrospinal fluid.
    Watchorn, E
    McCance, RA
    BIOCHEMICAL JOURNAL, 1933, 27 : 1107 - 1112
  • [33] The use of an electronic nose to characterize emissions from a highly polluted river
    Lamagna, Alberto
    Reich, Silvia
    Rodriguez, Daniel
    Boselli, Alfredo
    Cicerone, Daniel
    SENSORS AND ACTUATORS B-CHEMICAL, 2008, 131 (01) : 121 - 124
  • [34] Performance Evaluation of a Serum S-100B ELISA for Use with Cerebrospinal Fluid
    Erickson, J. Alan
    Grenache, David G.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2018, 2 (05): : 811 - 813
  • [35] Evaluation of screening for drug use using postmortem prolactin levels in serum and cerebrospinal fluid
    Tani, N.
    Ikeda, T.
    Aoki, Y.
    Shida, A.
    Oritani, S.
    Ishikawa, T.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2019, 38 (11) : 1244 - 1253
  • [36] Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration
    Ortner, Marion
    Goldhardt, O.
    Diehl-Schmid, J.
    Yakushev, I
    Lanz, K.
    Hedderich, D. M.
    Manuilova, E.
    Simon, M.
    Weinberger, J-P
    Grimmer, T.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2022, 9 (03): : 491 - 498
  • [37] A COMPARISON OF SIMPLE IDENTIFICATION TESTS TO DISTINGUISH CEREBROSPINAL-FLUID FROM LOCAL-ANESTHETIC SOLUTION
    TESSLER, MJ
    WIESEL, S
    WAHBA, RM
    QUANCE, DR
    ANAESTHESIA, 1994, 49 (09) : 821 - 822
  • [38] Dementing disorders: Volumetric measurement of cerebrospinal fluid to distinguish normal from pathologic findings - Feasibility study
    Thacker, NA
    Varma, AR
    Bathgate, D
    Stivaros, S
    Snowden, JS
    Neary, D
    Jackson, A
    RADIOLOGY, 2002, 224 (01) : 278 - 285
  • [39] Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
    Marion Ortner
    O. Goldhardt
    J. Diehl-Schmid
    I. Yakushev
    K. Lanz
    D. M. Hedderich
    E. Manuilova
    M. Simon
    J.-P. Weinberger
    T. Grimmer
    The Journal of Prevention of Alzheimer's Disease, 2022, 9 : 491 - 498
  • [40] Use of the paired samples (cerebrospinal fluid and serum) in immunodiagnostic of active and inactive human neurocysticercosis
    Barcelos, ISD
    Ferreira, MS
    de Moura, LP
    Biondi, GF
    Costa-Cruz, JM
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2005, 100 (04): : 427 - 429